Left Ventricular Physiology and Ventricular-Vascular Interactions in Young Patients After Heart Transplantation

Heiner Latus1,2, Ramona Raap1, Karin Klingel3

  • 1Pediatric Heart Centre, Centre for Congenital Heart Disease Giessen Germany.

Insights

Heart transplant recipients exhibit impaired ventriculo-arterial coupling, with increased arterial elastance (Ea) negatively impacting graft function. This highlights vascular dysfunction as a key factor in late graft failure.

Area of Science:

  • Cardiovascular Physiology
  • Transplantation Medicine
  • Vascular Biology

Background:

  • Systemic arterial hypertension and aortic stiffness increase ventricular afterload in heart transplant recipients, potentially causing graft dysfunction.
  • Understanding ventriculo-arterial coupling is crucial for assessing cardiovascular health post-transplantation.

Purpose of the Study:

  • To characterize systemic arterial elastance (Ea) and its impact on left ventricular function and ventriculo-arterial coupling in pediatric and young adult heart transplant survivors.
  • To evaluate these parameters using invasive conductance catheter technique.

Main Methods:

  • Invasive cardiac catheterization and pressure-volume loop analysis were performed on 30 heart transplant recipients.
  • Load-independent parameters including ventricular elastance (Ees) and ventricular compliance were assessed at rest and during dobutamine infusion.
  • Systemic arterial elastance (Ea) and ventriculo-arterial coupling (Ea/Ees) were calculated.

Main Results:

  • Ventricular elastance (Ees) increased appropriately with dobutamine, but ventricular compliance remained unchanged.
  • Ventriculo-arterial coupling (Ea/Ees) was abnormal at rest and did not improve with dobutamine due to a significant rise in systemic arterial elastance (Ea).
  • Both Ees and ventricular compliance were significantly associated with Ea.

Conclusions:

  • Heart transplant recipients demonstrate impaired ventriculo-arterial coupling, even with preserved left ventricular contractile reserve.
  • Increased afterload, driven by abnormal vascular function, is a significant factor contributing to late graft failure.
  • Monitoring vascular elastance and coupling is essential for managing long-term outcomes in heart transplant patients.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11